Efficacy and Safety of 675-nm Laser for Dorsal Hand Rejuvenation
ConditionWrinkle
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-65
SponsorMahidol University
About this trial
This study aimed to evaluate efficacy and safety of 675-nm laser for dorsal hand rejuvenation in Thai patients. Twenty-six subjects aged 50 to 65 years diagnosed with wrinkle and solar lentigines on both dorsums of hands were included and treated with RedTouch for 3 times every 4 weeks. Then, they were follow up at 3 and 6 months after the final treatment. The measurement of 5-point Global Aesthetic Improvement Scale scores by physicians and subjects were conducted. Moreover, pigmentation level, wrinkle and texture were also recored using Antera. Elasticity was measured using Cutometer.
Eligibility criteria
Qualifiers
Subjects diagnosed with wrinkles and solar lentigines on both dorsum of hands
Disqualifiers
Pregnant or lactation
Sugjects with a history of allergy to near-infrared wavelength or photosensitizing agents
Subjects who have been treated with any kind of energy-based device on both dorsum of hands 6 months prior to the inclusion
Subjects who have been injected with filler, or platelet-rich plasma on both dorsum of hands on their faces 6 months prior to the inclusion
Trial design
Treatments tested in this trial
- Redtouch
Treatment groups
26 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov